Coronary Artery Disease (CAD) is when the arteries that supply blood to your heart become narrow or blocked. This can cause chest pain, especially when you're active, and may lead to heart weakness or even a heart attack. This study looks at special proteins in the blood called biomarkers, which are higher in people with CAD. By lowering these biomarkers through personalized treatment, the study hopes to reduce CAD complications.

Participants will be split into two groups: one will receive personalized treatment based on their biomarkers, including medication adjustments and lifestyle changes. The other will get standard care from their doctor. The study will happen at Emory University Hospital and Woodruff Memorial Research Building.

Participants will have physical exams, blood tests, and complete questionnaires. They will be paid for participation, and their information may be shared for future research.

• The study will happen at Emory University Hospital.
• Participants get paid for being in the study.
• Participants will be randomly assigned to two groups.